Cargando…

Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction

High hydrostatic pressure specifically devitalizes cells and tissues without major changes in their molecular structure. Hence, high hydrostatic pressure may enhance the development of whole-cell anti-tumor vaccines, representing tumor heterogeneity and thus (neo-) antigen diversity. Moreover, safe...

Descripción completa

Detalles Bibliográficos
Autores principales: Maletzki, Claudia, Freiin Grote, Vivica, Kalle, Friederike, Kleitke, Thoralf, Zimpfer, Annette, Becker, Anne-Sophie, Bergmann-Ewert, Wendy, Jonitz-Heincke, Anika, Bader, Rainer, Vollmar, Brigitte, Hackenberg, Stephan, Scherzad, Agmal, Mlynski, Robert, Strüder, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593744/
https://www.ncbi.nlm.nih.gov/pubmed/37872173
http://dx.doi.org/10.1038/s41420-023-01671-z
_version_ 1785124496500326400
author Maletzki, Claudia
Freiin Grote, Vivica
Kalle, Friederike
Kleitke, Thoralf
Zimpfer, Annette
Becker, Anne-Sophie
Bergmann-Ewert, Wendy
Jonitz-Heincke, Anika
Bader, Rainer
Vollmar, Brigitte
Hackenberg, Stephan
Scherzad, Agmal
Mlynski, Robert
Strüder, Daniel
author_facet Maletzki, Claudia
Freiin Grote, Vivica
Kalle, Friederike
Kleitke, Thoralf
Zimpfer, Annette
Becker, Anne-Sophie
Bergmann-Ewert, Wendy
Jonitz-Heincke, Anika
Bader, Rainer
Vollmar, Brigitte
Hackenberg, Stephan
Scherzad, Agmal
Mlynski, Robert
Strüder, Daniel
author_sort Maletzki, Claudia
collection PubMed
description High hydrostatic pressure specifically devitalizes cells and tissues without major changes in their molecular structure. Hence, high hydrostatic pressure may enhance the development of whole-cell anti-tumor vaccines, representing tumor heterogeneity and thus (neo-) antigen diversity. Moreover, safe devitalization of tumor-infiltrated supporting tissue may facilitate reimplantation for functional reconstruction. However, precise high hydrostatic pressure thresholds for safe cancer cell killing are unknown. Here, we show that high hydrostatic pressure of at least 450 MPa is necessary to safely devitalize head and neck squamous cell cancer. A pressure of 300 MPa, which has been used frequently in cancer vaccine preparation, resulted in partial devitalization with 27% live cells in flow cytometry and 4% remaining autofluorescence in cell culture after one week. The remaining cells could form vital tumors in the chorioallantoic membrane assay. In contrast, 450 MPa killed all cells in vitro and prevented tumor outgrowth in ovo. The effectiveness of 450 MPa was attributed to the induction of DNA double-strand breaks, independent of apoptosis, autophagy, or methuosis. Furthermore, 450 MPa continued to induce immunogenic cell death. Our results demonstrate that 450 MPa of high hydrostatic pressure induces safe and sustained devitalization of head and neck cancer cells and tissues. Because of the heterogeneity in pressure resistance, we propose our approach as a starting point for determining the precise thresholds for other cancer entities. Further studies on head and neck cancer should focus on immunological co-cultures, combinations of immune checkpoint inhibition, and accurate anatomical reconstruction with pressure-treated autografts. [Image: see text]
format Online
Article
Text
id pubmed-10593744
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-105937442023-10-25 Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction Maletzki, Claudia Freiin Grote, Vivica Kalle, Friederike Kleitke, Thoralf Zimpfer, Annette Becker, Anne-Sophie Bergmann-Ewert, Wendy Jonitz-Heincke, Anika Bader, Rainer Vollmar, Brigitte Hackenberg, Stephan Scherzad, Agmal Mlynski, Robert Strüder, Daniel Cell Death Discov Article High hydrostatic pressure specifically devitalizes cells and tissues without major changes in their molecular structure. Hence, high hydrostatic pressure may enhance the development of whole-cell anti-tumor vaccines, representing tumor heterogeneity and thus (neo-) antigen diversity. Moreover, safe devitalization of tumor-infiltrated supporting tissue may facilitate reimplantation for functional reconstruction. However, precise high hydrostatic pressure thresholds for safe cancer cell killing are unknown. Here, we show that high hydrostatic pressure of at least 450 MPa is necessary to safely devitalize head and neck squamous cell cancer. A pressure of 300 MPa, which has been used frequently in cancer vaccine preparation, resulted in partial devitalization with 27% live cells in flow cytometry and 4% remaining autofluorescence in cell culture after one week. The remaining cells could form vital tumors in the chorioallantoic membrane assay. In contrast, 450 MPa killed all cells in vitro and prevented tumor outgrowth in ovo. The effectiveness of 450 MPa was attributed to the induction of DNA double-strand breaks, independent of apoptosis, autophagy, or methuosis. Furthermore, 450 MPa continued to induce immunogenic cell death. Our results demonstrate that 450 MPa of high hydrostatic pressure induces safe and sustained devitalization of head and neck cancer cells and tissues. Because of the heterogeneity in pressure resistance, we propose our approach as a starting point for determining the precise thresholds for other cancer entities. Further studies on head and neck cancer should focus on immunological co-cultures, combinations of immune checkpoint inhibition, and accurate anatomical reconstruction with pressure-treated autografts. [Image: see text] Nature Publishing Group UK 2023-10-23 /pmc/articles/PMC10593744/ /pubmed/37872173 http://dx.doi.org/10.1038/s41420-023-01671-z Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Maletzki, Claudia
Freiin Grote, Vivica
Kalle, Friederike
Kleitke, Thoralf
Zimpfer, Annette
Becker, Anne-Sophie
Bergmann-Ewert, Wendy
Jonitz-Heincke, Anika
Bader, Rainer
Vollmar, Brigitte
Hackenberg, Stephan
Scherzad, Agmal
Mlynski, Robert
Strüder, Daniel
Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
title Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
title_full Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
title_fullStr Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
title_full_unstemmed Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
title_short Establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
title_sort establishing safe high hydrostatic pressure devitalization thresholds for autologous head and neck cancer vaccination and reconstruction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593744/
https://www.ncbi.nlm.nih.gov/pubmed/37872173
http://dx.doi.org/10.1038/s41420-023-01671-z
work_keys_str_mv AT maletzkiclaudia establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT freiingrotevivica establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT kallefriederike establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT kleitkethoralf establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT zimpferannette establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT beckerannesophie establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT bergmannewertwendy establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT jonitzheinckeanika establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT baderrainer establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT vollmarbrigitte establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT hackenbergstephan establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT scherzadagmal establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT mlynskirobert establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction
AT struderdaniel establishingsafehighhydrostaticpressuredevitalizationthresholdsforautologousheadandneckcancervaccinationandreconstruction